PhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 104 | Founded | a year ago | Last Issue | 2 days ago |
| Active | |||||
Read this Newsletter
spatialplex.substack.comLatest Issues
Invivyd (IVVD): A BIG bet for a Vaccine Alternative?
This is one play that has so much enthusiasm behind it.
This is one play that has so much enthusiasm behind it.
[ii]–Neurocrine Biosciences (NBIX) 🚨. Scientific & Financial Deep Dive: INGREZZA's IRA Cliff, the CRENESSITY Ramp and a $2.9B Bet on VYKAT
This is a part (ii) piece for NBIX: The scientific deep dive for pipeline products.
This is a part (ii) piece for NBIX: The scientific deep dive for pipeline products.
[i]–Neurocrine Biosciences (NBIX) 🚨. Scientific & Financial Deep Dive: INGREZZA's IRA Cliff, the CRENESSITY Ramp and a $2.9B Bet on VYKAT
A subscriber asked me to do some work on NBIX.
A subscriber asked me to do some work on NBIX. This is a commercial stage ticker, and so it is slightly different from most of the tickers we have covered.
The Biotech Week Ahead: October 12 to 16, 2026
We are headed to mid October and the biotech market sentiment for the most part is HOLD.
We are headed to mid October and the biotech market sentiment for the most part is HOLD. The XBI finished last week almost flat, down about 0.4%, afte...
[Update]Talphera: Nothing Broke. The Clock Just Got Longer.
Topline will be delayed, The science still holds, The 4x upside is still possible
Folks,
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for JojoFinanceNotes.
| Subscribers | Engagement | 75 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
PhD scientist || Over TEN years researching Infectious diseases and Immuno-oncology | Hunting the next Biotech breakthrough investments by breaking down the science.
Frequently Asked Questions
How can I access the email archive for JojoFinanceNotes?
You can find recent issues that have been published by JojoFinanceNotes on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does JojoFinanceNotes have?
To see how many people subscribe to JojoFinanceNotes, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in JojoFinanceNotes?
Newsletter advertising can be extremely effective when it's done right. Before you pitch JojoFinanceNotes as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like JojoFinanceNotes?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact JojoFinanceNotes using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to JojoFinanceNotes?
Scroll up to where it says Related Newsletters to see other publications like JojoFinanceNotes. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact JojoFinanceNotes?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.